Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met

First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years...

Mar 14, 20235 min read

2,436 views

Acesion Pharma Strengthens Clinical Team with Key Appointments

Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac...

May 5, 20202 min read

421 views

Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...

Mar 12, 20192 min read

212 views